BNP Paribas Financial Markets’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-27,050
| Closed | -$303K | – | 3624 |
|
|
2017
Q3 | $303K | Buy |
27,050
+10,910
| +68% | +$122K | ﹤0.01% | 1982 |
|
|
2017
Q2 | $178K | Buy |
16,140
+5,658
| +54% | +$62.2K | ﹤0.01% | 2163 |
|
|
2017
Q1 | $103K | Buy |
10,482
+1,320
| +14% | +$12.9K | ﹤0.01% | 2096 |
|
|
2016
Q4 | $99K | Buy |
9,162
+2,144
| +31% | +$23.2K | ﹤0.01% | 2151 |
|
|
2016
Q3 | $71.9K | Sell |
7,018
-8,567
| -55% | -$87.8K | ﹤0.01% | 2267 |
|
|
2016
Q2 | $204K | Buy |
+15,585
| New | +$204K | ﹤0.01% | 1889 |
|
|
2016
Q1 | – | Sell |
-9,340
| Closed | -$85.9K | – | 3410 |
|
|
2015
Q4 | $85.9K | Sell |
9,340
-1,104
| -11% | -$10.2K | ﹤0.01% | 2442 |
|
|
2015
Q3 | $72.5K | Buy |
10,444
+6,318
| +153% | +$43.8K | ﹤0.01% | 2607 |
|
|
2015
Q2 | $40.5K | Buy |
4,126
+2,898
| +236% | +$28.5K | ﹤0.01% | 2618 |
|
|
2015
Q1 | $10.9K | Buy |
+1,228
| New | +$10.9K | ﹤0.01% | 2701 |
|
|
2014
Q4 | – | Sell |
-2,893
| Closed | -$19.9K | – | 3264 |
|
|
2014
Q3 | $19.9K | Buy |
2,893
+2,811
| +3,428% | +$19.4K | ﹤0.01% | 2702 |
|
|
2014
Q2 | $431 | Sell |
82
-345
| -81% | -$1.81K | ﹤0.01% | 3129 |
|
|
2014
Q1 | $2.04K | Sell |
427
-612
| -59% | -$2.93K | ﹤0.01% | 2217 |
|
|
2013
Q4 | $5.24K | Sell |
1,039
-14,039
| -93% | -$70.8K | ﹤0.01% | 2577 |
|
|
2013
Q3 | $76.4K | Sell |
15,078
-2,816
| -16% | -$14.3K | ﹤0.01% | 2138 |
|
|
2013
Q2 | $88.8K | Buy |
+17,894
| New | +$88.8K | ﹤0.01% | 2233 |
|